Hepatitis C symptoms and diagnosis

Hepatitis C symptoms and diagnosis features

• 

  The new epidemic: HIV and hepatitis C infection in gay men

  “I’m surprised there isn’t a greater sense of urgency about this in the community.” Those were the words of Dr Kevin Fenton of the US Centers for...

  From:  HIV treatment update

• 

  Management of HIV and hepatitis B or C co-infection in resource-limited settings

  Review of management of HIV and hepatitis co-infection with particular focus on antiretroviral therapy and liver disease in resource-limited settings....

  From:  HIV & AIDS treatment in practice

Hepatitis C symptoms and diagnosis in your own words

• 

  Living with HIV and hep C co-infection and haemophilia

  For most people, coping with HIV is enough of a problem in itself, but when you throw in a lifetime disorder such as haemophilia, and...

  From: In your own words

Hepatitis C symptoms and diagnosis news from aidsmap

• Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended

  There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in western Europe, researchers report in the Journal of Viral Hepatitis.Over years or decades, chronic hepatitis B or C can cause serious liver disease ...

  10 June 2019 | Roger Pebody

• Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer

  People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably associated with the improved effectiveness of antiretroviral treatment, a French study has ...

  14 January 2019 | Keith Alcorn

• Majority of US young adults who use drugs are not tested for hepatitis C or HIV

  Only about a third of adolescents and young adults diagnosed with opioid use disorder in the United States are screened for hepatitis C virus (HCV) or HIV, even though injection drug use is one of the main risk factors ...

  19 October 2018 | Liz Highleyman

• Supervised drug consumption sites offer opportunities for HCV testing and treatment

  Most supervised drug consumption facilities offer hepatitis C virus (HCV) testing and referrals, but very few offer treatment, indicating that they could potentially play a greater role in curbing transmission and negative health outcomes related to hepatitis C, according to ...

  27 July 2018 | Liz Highleyman

• Do fatigue and quality of life improve after hepatitis C is cured?

  Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people with cirrhosis, but people with cirrhosis are less likely than others to experience rapid resolution ...

  16 May 2018 | Keith Alcorn

• More work and lower drug prices are needed to eliminate hepatitis C worldwide

  Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do this more people need to be tested and treated and prices of direct-acting antivirals (DAAs) need to come down, according ...

  29 November 2017 | Liz Highleyman

• Nivolumab improves outcomes in liver cancer study

  Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease stabilisation in people with hepatocellular carcinoma (HCC) in the CheckMate 040 study, according to a report at the ...

  14 November 2017 | Liz Highleyman

• Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

  Nine countries – Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, the Netherlands and Qatar – are on course to eliminate hepatitis C by 2030, according to data released at the World Hepatitis Summit in São Paulo, Brazil, this ...

  01 November 2017 | Keith Alcorn

• UK elimination of hepatitis C in jeopardy unless more patients found

  Just one in three people with hepatitis C in the United Kingdom has been diagnosed according to the latest estimates released at this year’s World Hepatitis Summit in São Paulo, Brazil (1-3 November). The estimate comes from ...

  01 November 2017 | Keith Alcorn

• Hepatitis C testing linked to reduced opioid use among people who inject drugs

  Getting tested for hepatitis C virus (HCV) was associated with reduced drug use, especially among those who tested positive, but even people who tested negative saw some reduction, according to study results presented at the 2017 AASLD Liver Meeting ...

  25 October 2017 | Liz Highleyman

More news

Hepatitis C symptoms and diagnosis news selected from other sources

• Slight decline in hepatitis C diagnoses in Europe

  European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area (EU/EEA). In addition, variation in national testing practices and widespread under-reporting of diagnosed cases do not provide an accurate picture of the true epidemiological burden.

  03 April 2019 | Eurekalert Inf Dis

• Expert working group recommends bold action to eliminate hepatitis C in Scotland; now we need a national elimination strategy

  A new report published by Health Protection Scotland sets out national recommendations for improvements to case finding and access to care which would accelerate Scotland’s efforts to eliminate hepatitis C. The Hepatitis C Trust calls on the Scottish Government to set out a clear timeline and process for developing and releasing a national elimination strategy for hepatitis C, in order to facilitate implementation of the recommendations contained in the recent Health Protection Scotland report.

  19 February 2019 | Hepatitis C Trust

• Low testosterone persists after HCV clearance

  Low levels of free testosterone are common among men with chronic hepatitis C infection following SVR and persist after HCV clearance, according to findings from a prospective, longitudinal cohort study.

  12 February 2019 | Healio

• Hepatitis C Prevalent in Less Than 1% of US Population

  Epidemiologists found a 0.93% overall prevalence of hepatitis C virus (HCV) infection cases in the US while using a novel assessment method in a new study. The report, which included undiagnosed cases among its prevalence rates, found that approximately half of the cases occurred in just 9 states, including 5 in Appalachia.

  18 January 2019 | MD Magazine

• Undiagnosed HBV, HCV, HIV prevalent in newly diagnosed cancer cases

  Researchers discovered a substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis C or hepatitis B were unaware of their viral infection and many had no identifiable risk factors, according to a recently published study.

  18 January 2019 | Healio

• Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

  When hepatitis C (HCV) is acquired in patients with HIV infection, CD4 T-cell counts temporarily decline after HCV seroconversion, regardless of the duration of HIV or whether the patient is on combination antiretroviral therapy (cART), according to study findings published in AIDS.

  09 January 2019 | Infectious Disease Advisor

• 19 million Egyptians screened for Hepatitis C since launch of eradication campaign: Health minister

  Egypt's Minister of Health Hala Zayed has announced that nearly 19 million citizens have been screened for Hepatitis C and other non-communicable diseases as part of the '100 Million Lives' campaign, the largest-ever nationwide campaign to eradicate hepatitis C launched last October.

  18 December 2018 | Ahram Online

• Millions flock to free tests as Egypt seeks to eradicate hepatitis C

  Egypt, which has the highest rate of hepatitis C in the world, is carrying out an unprecedented campaign to detect and treat the disease in a bid to eliminate it by 2022. It aims to test the entire adult population — about 50 million people.

  06 December 2018 | Reuters

• 4.5 percent of examined Egyptians tested positive for Hepatitis C

  Minister of Health and Population HalaZayed said that the tests carried out as part of Egypt’s national campaign’s first stage revealed that 4.5 percent of the examined citizens tested positive for Hepatitis C.

  22 November 2018 | Egypt Today

• PHE and NHSE launch national drive to trace hepatitis C patients

  Public Health England (PHE) and NHS England have launched a national exercise to identify and treat patients who have been previously diagnosed with hepatitis C.

  21 November 2018 | GOV.UK

More news